Sympathetic Nervous System Function and Dysfunction in Chronic Hemodialysis Patients

Seminars in Dialysis

Volumn 26, Issue 3, 2013, Pages 333-343

  Rubinger, Dvora ^a   Backenroth, Rebecca ^a   Sapoznikov, Dan ^a  

^a HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENERGIC SYSTEM; ARTICLE; CHRONIC KIDNEY FAILURE; HUMAN; PATHOPHYSIOLOGY; PHYSIOLOGY; RENAL REPLACEMENT THERAPY;

HUMANS; KIDNEY FAILURE, CHRONIC; RENAL DIALYSIS; SYMPATHETIC NERVOUS SYSTEM;

EID: 84878014763     PISSN: 08940959     EISSN: 1525139X     Source Type: Journal    
DOI: 10.1111/sdi.12093     Document Type: Article

References (146)

1. Tjusi H, Larson MG, Venditti FJ, Manders ES, Evans JC, Feldman CL, Levy D: Impact of reduced heart rate variability on risk for cardiac events: The Framingham Heart Study. Circulation 94(11):2850-2855, 1996
2. Lahiri MK, Kannankeril PJ, Goldberger J: Assessment of autonomic function in cardiovascular disease: physiological basis and prognostic implications. J Am Coll Cardiol 51(18):1725-1733, 2008.
3. Curtis BM, O' Keefe JH Jr: Autonomic tone as cardiovascular risk factor: the dangers of chronic fight or flight. Mayo Clin Proc 77(1):45-54, 2002
4. Malpas SC: Sympathetic nervous system overactivity and its role in the development of cardiovascular disease. Physiol Rev 90(2):513-557, 2010.
5. Augustyniak RA, Tuncel M, Zhang W, Toto RD, Victor RG: Sympathetic overactivity as a cause of hypertension in chronic renal failure. J Hypertension 20(1):3-9, 2002.
6. Converse RL Jr, Jacobsen TN, Toto RD, Jost CM, Cosentino F, Fouad-Tarazi F, Victor RG: Sympathetic overactivity in patients with chronic renal failure. New Engl J Med 327(27):1912-1918, 1992
7. Converse RL Jr, Jacobsen TN, Jost CM, Toto RD, Grayburn PA, Obregon TM, Fouad-Tarazi F, Victor RG: Paradoxical withdrawal of reflex vasoconstriction as a cause of hemodialysis-induced hypotension. J Clin Invest 90(5):1657-1665, 1992
8. Masuo K, Lambert GW, Esler MD, Rakugi H, Ogihara T, Schlaich MP: The role of sympathetic nervous activity in renal injury and end-stage renal disease. Hypertens Res 33(6):521-528, 2010
9. Grassi G: Assessment of sympathetic cardiovascular drive in human hypertension; achievements and perspectives. Hypertension 54(4):690-697, 2009
10. Blankestijn PJ, Ligtenberg G: Volume-independent mechanisms of hypertension in hemodialysis patients: clinical implications. Semin Dial 17(4):265-269, 2004
11. Vonend O, Rump CL, Ritz E: Sympathetic overactivity-the Cinderella of cardiovascular risk factors in dialysis patients. Semin Dial 21(4):326-330, 2008
12. Schlaich MP: Sympathetic activation in chronic kidney disease. Out of the shadow. Hypertension 57(4):683-685, 2011
13. Grassi G, Bertoli S, Servalle G: Sympathetic nervous system; role in hypertension and in chronic kidney disease. Curr Opin Nephrol Hypertens 21(1):46-51, 2012
14. Vink EE, Blankestijn PJ: Evidence and consequences of the central role of the kidneys in the pathophysiology of sympathetic hyperactivity. Frontiers in Physiol 3:29, 2012. Epub. February 20, 2012
15. Hausberg M, Kosch M, Harmelink P, Barenbrock M, Hohage H, Kisters K, Dietl KH, Rahn KH: Sympathetic nerve activity in end-stage renal disease. Circulation 106(15):1974-1979, 2002
16. Testa A, Malllamaci F, Macri R, Pisano A, Spoto B, Malatino LS, Stancanelli B, Tripepi G, Benedetto FA, Zoccali C: Neuropeptide Y receptor Y2 gene polymorphism interacts with plasma neuropeptide Y levels in predicting left ventricular hypertrophy in dialysis patients. J Hypertens 28(8):1745-1751, 2010
17. Robinson TG, Carr SJ: Cardiovascular autonomic dysfunction in uremia. Kidney Int 62(6):1921-1932, 2002
18. Bigazzi R, Kogosov E, Campese VM: Altered norepinephrine turnover in the brown fat of rats with chronic renal failure. J Am Soc Nephrol 4(11):1896-1900, 1994
19. Bigazzi R, Kogosov E, Campese VM: Altered norepinephrine turnover in the brain of rats with chronic renal failure. J Am Soc Nephrol 4(11):1901-1907, 1994
20. Eisenhofer G, Huysmans F, Pacak K, Walther MM, Sweep FC, Lenders JW: Plasma metanephrines in renal failure. Kidney Int 67(2):668-677, 2005
21. Izzo JL Jr, Santarosa RP, Larrabee PS, Smith RJ, Kallay MC: Increased plasma norepinephrine and sympathetic nervous activity in essential hypertensive and uremic humans: effects of clonidine. J Cardiovasc Pharm 10(Suppl 12):S225-S229, 1987
22. Esler M: The sympathetic nervous system through the ages: from Thomas Willis to resistant hypertension. Exp Physiol 96(7):611-622, 2011
23. Mano T, Iwase S, Toma S: Microneurography as a tool in clinical neurophysiology to investigate peripheral neural traffic in humans. Clin Neurophysiol 117(11):2357-2384, 2006
24. Ligtenberg G, Blankestijn PJ, Oey L, Klein IHH, Dijkhorst-Oei LT, Boosma F, Wieneke GH, van Huffelen AC, Koomans HA: Reduction of sympathetic hyperactivity by enalapril in patients with chronic renal failure. N Engl J Med 340(17):1321-1328, 1999
25. Klein IH, Ligtenberg G, Oey PL, Koomans HA, Blankestijn PJ: Sympathetic activity is increased in polycystic kidney disease and is associated with hypertension. J Am Soc Nephrol 12(11):2427-2433, 2001
26. Grassi G, Quarti-Trevano F, Seravalle G, Arenare F, Volpe M, Furiani S, Dell'Oro R, Mancia G: Early sympathetic activation in the initial clinical stages of chronic renal failure. Hypertension 57(4):846-851, 2011
27. Parati G, Saul JP, Di Rienzo M, Mancia G: Spectral analysis of blood pressure and heart rate variability in evaluating cardiovascular regulation. A critical appraisal. Hypertension 25(6):1276-1286, 1995
28. Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology: Heart rate variability. Standards of measurement, physiological interpretation, and clinical use. Eur Heart J 17(3):354-381, 1996
29. Norton MR, Sloan RP, Bagiella E: New approach to the statistical analysis of cardiovascular data. J Appl Physiol 98(6):2298-2303, 2005
30. Parati G, Di Rienzo M, Mancia G: How to measure baroreflex sensitivity: from the cardiovascular laboratory to daily life. J Hypertension 18(1):7-19, 2000
31. Elghozi JL, Julien C: Sympathetic control of short-term heart rate variability and its pharmacological modulation. Fundam Clinical Pharmacology 21(4):337-347, 2007
32. Kim YH, Ahmed MW, Kadish AH, Goldberger JJ: Characterization of factors that determine the effect of sympathetic stimulation on heart rate variability. Pacing Clin Electrophysiol 20(8 Pt 1):1936-1946, 1997
33. Ahmed MW, Kadish AH, Parker MA, Goldberger JJ: Effect of physiologic and pharmacologic stimulation on heart rate variability. J Am Coll Cardiol 24(4):1082-1090, 1994
34. Saul JP, Rea RF, Eckberg DL, Berger RD, Cohen JC: Heart rate and muscle sympathetic nerve variability during reflex changes of autonomic activity. Am J Physiol 258 (Heart Circ Physiol 27): H713-H721, 1990
35. Stauss HM: Identification of blood pressure control mechanisms by power spectral analysis. Clin Exp Pharmacol Physiol 34(4):362-368, 2007
36. Pagani M, Montano N, Porta A, Malliani A, Abboud FM, Birkett C, Somers VK: Relationship between spectral components of cardiovascular variabilities and direct measure of muscle sympathetic activity in humans. Circulation 18(12):1441-1448, 1997
37. Brychta RJ, Shiavi R, Robertson D, Biaggioni I, Diedrich A: A simplified two-component model of blood pressure fluctuation. Am J Physiol Heart Circ Physiol 292(2):H1193-H1203, 2007
38. Mancia G, Parati G, Castiglioni P, Di Rienzo M: Effect of sinoaortic denervation on frequency-domain estimates of baroreceptor sensitivity in conscious cats. Am J Physiol Heart Circ Physiol 276(6 Pt 2):H1987-H1993, 1999
39. Diaz T, Taylor JA: Probing the arterial baroreflex: is there a "spontaneous" baroreflex? Clin Auton Res 16(4):256-261, 2006
40. La Rovere MT, La Pina GD, Raczak G: Baroreflex sensitivity; measurement and clinical implications. Ann Noninvasive Electrocardiol 13(2):191-207, 2008
41. Di Rienzo M, Parati G, Castiglioni P, Tordi R, Mancia G, Pedotti A: Baroreflex effectiveness index: an additional measure of baroreflex control of heart rate in daily life. Am J Physiol Regul Integr Comp Physiol 280(3):R744-R751, 2001
42. Pagani M, Somers V, Furlan R, Dell'Orto S, Conway J, Baselli G, Cerutti S, Sleight P, Malliani A: Changes in autonomic regulation induced by physical training in mild hypertension. Hypertension 12(6):600-610, 1988
43. Laude D, Elghozi JL, Girard A, Bellard E, Bouhaddi M, Castiglioni P, Cerutti C, Cividjian A, Di Rienzo M, Fortrat JO, Janssen B, Karemaker JM, Lefthériotis G, Parati G, Persson PB, Porta A, Quintin L, Regnard J, Rüdiger H, Stauss HM: Comparison of various techniques used to estimate spontaneous baroreflex sensitivity (the EuroBaVar study). Am J Physiol Regul Integr Comp Physiol 286(1):R226-R231, 2004
44. Hayano J, Taylor JA, Mukai S, Okada A, Watanabe Y, Takata K, Fujinami T: Assessment of frequency shifts in R-R interval variability and respiration with complex demodulation. J Appl Physiol 77(6):2879-2888, 1994
45. Suzuki M, Hiroshi T, Aoyama T, Tanaka M, Ishii H, Kisohara M, Iizuka N, Murohara T, Hayano J: Nonlinear measures of heart rate variability and mortality risk in hemodialysis patients. Clin J Am Soc Nephrol 7(9):1454-1460, 2012
46. Malpas SC: Neural influence on cardiovascular variability; possibilities and pitfalls. Am J Physiol Heart Circ Physiol 282(1):H6-H20, 2002
47. Rubinger D, Sapoznikov D, Pollak A, Popovtzer MM, Luria MH: Heart rate variability during chronic hemodialysis and after renal transplantation; studies in patients without and with systemic amyloidosis. J Am Soc Nephrol 10(9):1972-1981, 1999
48. Rubinger D, Backenroth R, Sapoznikov D: Restoration of baroreflex function in patients with end-stage renal disease after renal transplantation. Nephrol Dial Transplant 24(4):1305-1313, 2009
49. Giordano M, Manzella D, Paolisso G, Caliendo A, Varrichio M, Giordano C: Differences in heart rate variability parameters during the post-dialytic period in type II diabetic and non-diabetic ESRD patients. Nephrol Dial Transplant 16(3):566-573, 2001
50. Rubinger D, Revis N, Pollak A, Luria MH: Predictors of hemodynamic instability and heart rate variability during hemodialysis. Nephrol Dial Transplant 19(8):2053-2060, 2004
51. Barnas MG, Boer WH, Koomans HA: Hemodynamic patterns and spectral analysis of heart rate variability during dialysis hypotension. J Am Soc Nephrol 10(12):2577-2584, 1999
52. Ferrario M, Raimann JG, Thijssen S, Signorini MG, Kruse A, Diaz-Buxo JA, Cerutti S, Levin NW, Kotanko P: Effects of dialysate glucose concentration on heart rate variability in chronic hemodialysis patients: results of a prospective randomized trial. Kidney Blood Press Res 34(5):334-343, 2011
53. Zitt E, Neyer U, Meusburger E, Tiefenthaler M, Kotanko P, Mayer G, Rosenkranz AR: Effect of dialysate temperature and diabetes on autonomic cardiovascular regulation during hemodialysis. Kidney Blood Press Res 31(4):217-225, 2008
54. Ferrario M, Moissl U, Garzotto F, Signorini MG, Cruz D, Tetta C, Ronco C, Gatti E, Cerutti S: Study of the autonomic response in hemodialysis patients with different fluid overload levels. Conf Proc IEEE Eng Med Biol Soc 2010:3796-3799, 2010
55. Polak G, Strózecki P, Grześk G, Manitius J, Grabczewska Z, Przybyl R: Effect of parathormone on heart rate variability in hemodialysis patients. Auton Neurosci 115(1-2):94-98, 2004
56. Mylonopoulou M, Tentolouris N, Antonopoulos S, Mikros S, Katsaros K, Melidonis A, Sevastos N, Katsilambros N: Heart rate variability in advanced chronic kidney disease with or without diabetes: midterm effects of the initiation of chronic haemodialysis therapy. Nephrol Dial Transplant 25(11):3749-3754, 2010
57. Notarius CF, Floras JS: Limitations of the use of spectral analysis of heart rate variability for the estimation of cardiac sympathetic activity in heart failure. Europace 3(1):29-38, 2001
58. Dhein S, Röhnert P, Markau S, Kotchi-Kotchi E, Becker K, Poller U, Osten B, Brodde OE: Cardiac beta-adrenoreceptors in chronic uremia: studies in humans and rats. J Am Coll Cardiol 36(2):608-617, 2000
59. Leineweber K, Heinroth-Hoffmann I, Pönicke K, Abraham G, Osten B, Brodde OE: Cardiac beta-adrenoreceptors desensitization due to increased beta-adrenoreceptor kinase activity in chronic uremia. J Am Soc Nephrol 13(1):117-124, 2002
60. Forsström J, Forsström J, Heinonen E, Välimäki I, Antila K: Effects of haemodialysis on heart rate variability in chronic renal failure. Scand J Clin Lab Invest 46(7):665-670, 1986
61. Weise F, London GM, Pannier BM, Guerin AP, Elghozi JL: Effect of hemodialysis on cardiovascular rhythms in end stage renal failure. Kidney Int 47(5):1443-1452, 1995
62. Cavalcanti S, Severi S, Chiari L, Avanzolini G, Enzmann G, Bianco G, Panzetta G: Autonomic nervous function during hemodialysis assessed by spectral analysis of heart-rate variability. Clin Sci 92(4):351-359, 1997
63. Pelosi G, Emdin M, Carpeggiani C, Morales MA, Piacenti M, Dattolo P, Cerrai T, Macerata A, L'Abbate A, Maggiore Q: Impaired sympathetic response before intradialytic hypotension; a study based on spectral analysis of heart rate and pressure variability. Clin Sci 96(1):23-31, 1999
64. Galetta F, Cupisti A, Franzoni F, Morelli E, Caprioli R, Rindi P, Barsotti G: Changes in heart rate variability in chronic uremic patients during ultrafiltration and hemodialysis. Blood Purif 19(4):395-400, 2001
65. Yoshii M, Minami J, Ishimitsu T, Yamakoshi K, Matsuoka H: Non-invasive monitoring of hemodynamic changes during hemodialysis by the use of a newly developed admittance cardiograph. Ther Apher Dial 9(2):154-160, 2005
66. Genovesi S, Bracchi O, Fabbrini P, Luisetto E, Viganò MR, Lucini D, Malacarne M, Stella A, Pagani M: Differences in heart variability during haemodialysis and haemofiltration. Nephrol Dial Transplant 22(8):2256-2262, 2007
67. Tong YQ, Hou HM: Alteration of heart rate variability parameters in nondiabetic hemodialysis patients. Am J Nephrol 27(1):63-69, 2007
68. Javed F, Middelton PM, Malouf P, Chan GS, Savkin AV, Lovell NH, Steel E, Mackie J: Frequency spectrum analysis of finger plethysmographic waveform variability during hemodialysis. Physiol Meas 31(9):1203-1216, 2010
69. Sapoznikov D, Backenroth R, Rubinger D: Baroreflex sensitivity and sympatho-vagal balance during intradialytic hypotensive episodes. J Hypertens 28(2):314-324, 2010
70. Titapiccolo JI, Cerutti S, Garzotto F, Cruz D, Moissl U, Tetta C, Signorini MG, Ronco C, Ferrario M: Alteration of autonomic blood pressure control during hemodialysis in peripheral vascular disease patients. Conf Proc IEEE Eng Med Biol Soc, 2011:5511-5514, 2011
71. Ino-Oka E, Urae J, Sekino M, Satoh M, Takeuchi K, Sekino H, Ohtaki Y, Inooka H: Blood pressure and sympathetic nerve tone relation during hemodialysis may reflect cardiovascular dysfunction. Intern Med 50(22):2741-2748, 2011
72. González H, Infante O, Pérez-Grovas H, Jose MV, Lerma C: Non-linear dynamics of heart rate variability in response to orthostatism and hemodialysis in chronic renal failure patients: recurrence analysis approach. Med Eng Phys 35(2):178-187, 2012
73. Yamamoto K, Kobayashi N, Kutsuna T, Ishii A, Matsumoto T, Hara M, Aiba N, Tabata M, Takahira N, Masuda T: Excessive fall of blood pressure during maintenance hemodialysis in patients with chronic renal failure is induced by vascular malfunction and imbalance of autonomic activity. Ther Apher Dial 16(3):219-225, 2012
74. Javed F, Savkin AV, Chan GSH, Mackie JD, Lovell NH: Recent advances in the monitoring and control of haemodynamic variables during haemodialysis: a review. Physiol Meas 33(1):R1-R31, 2012
75. Henderson LW: Symptomatic intradialytic hypotension and mortality: an opinionated review. Semin Dial, 25(3):320-325, 2012
76. Capuano A, Sepe V, Cianfrone P, Castellano T, Andreucci VE: Cardiovascular impairment, dialysis strategy and tolerance in elderly and young patients on maintenance hemodialysis. Nephrol Dial Transplant 5(12):1023-1030, 1990
77. Shoji T, Tsubakihara Y, Fuji M, Imai E: Hemodialysis associated hypotension as an independent risk factor for two-year mortality in hemodialysis patients. Kidney Int 66(3):1212-1220, 2004
78. Sato M, Horigome I, Chiba S, Furuta T, Miayazaki M, Hotta O, Suzuki K, Noshiro H, Taquma Y: Autonomic insufficiency as a factor contributing to dialysis-induced hypotension. Nephrol Dial Transplant 16(6):1657-1662, 2001
79. Zoccali C, Tripepi G, Mallamaci F, Panuccio V: The heart rate response pattern to dialysis hypotension in haemodialysis patients. Nephrol Dial Transplant 12(3):519-523, 1997
80. Campagna JA, Carter C: Clinical relevance of the Bezold-Jarisch reflex. Anesthesiology 98(5):1250-1260, 2003
81. Chesterton LJ, Selby NM, Burton JO, Fialova J, Chan C, McIntyre CW: Categorization of the hemodynamic response to hemodialysis: the importance of baroreflex sensitivity. Hemodial Int 14(1):18-20, 2010
82. Inrig JK: Intradialytic hypertension: a less-recognized cardiovascular complication of hemodialysis. Am J Kidney Dis 55(3):580-589, 2010
83. Chazot C, Jean G: Intradialytic hypertension: it is time to act. Nephron Clin Pract 115(3):c182-c188, 2010
84. Dolson GM, Ellis KJ, Bernardo MV, Prakash R, Adrogué HJ: Acute decreases in serum potassium augment blood pressure. Am J Kidney Dis 26(2):321-326, 1995
85. Van Kujik WH, Mulder AW, Peels CH, Harff GA, Leunissen KM: Influence of changes in ionized calcium on cardiovascular reactivity during hemodialysis. Clin Nephrol 47(3):190-196, 1997
86. Boulager CM, Amabile N, Guérin AP, Pannier B, Leroyer AS, Mallat CN, Tedqui A, London GM: In vivo shear stress determines circulating levels of endothelial microparticles in end-stage renal disease. Hypertension 49(4):902-908, 2007
87. Katzarski KS, Randmaa I, Bergsrtöm J: Influence of hemodialysis on intravascular volume and vasoactive hormones. Clin Nephrol 52(5):304-311, 1999
88. Hörl MP, Hörl WH: Hemodialysis-associated hypertension: pathophysiology and therapy. Am J Kidney Dis 39(2):227-244, 2002
89. Raj DS, Vincent B, Simpson K, Sato E, Jones KL, Welbourne TC, Levi M, Shah V, Blandon P, Zager P, Robbins RA: Hemodynamic changes during hemodialysis: role of nitric oxide and endothelin. Kidney Int 61(2):697-704, 2002
90. Inrig JK, Van Buren P, Kim C, Vongpatanasin W, Povsic TJ, Toto RD: Intradialytic hypertension and its association with endothelial cell dysfunction. Clin J Am Soc Nephrol 6(8):2016-2024, 2011
91. Hegbrant J, Thysell H, Märtensson L, Ekman R, Boberg U: Changes in plasma levels of vasoactive peptides during standard bicarbonate hemodialysis. Nephron 63(10):303-308, 1993
92. Chou KJ, Lee PT, Chen CL, Chiou CW, Hsu CY, Chung HM, Liu CP, Fang HC: Physiological changes during hemodialysis in patients with intradialysis hypertension. Kidney Int 69(10):1833-1838, 2006
93. Rubinger D, Backenroth R, Sapoznikov D: Sympathetic activation and baroreflex function during intradialytic hypertensive episodes. PLoS ONE 7(5):e36943, 2012
94. Castiglioni P, DiRienzo M, Parati G: How should the baroreflex sensitivity on the heart be estimated? J Electrocardiol 44(3):391-392, 2011
95. Legramante JM, Raimondi G, Massaro M, Cassarino S, Peruzzi G, Iellamo F: Investigating feed-forward neural regulation of circulation from analysis of spontaneous arterial pressure and heart rate fluctuations. Circulation 99(3):1760-1766, 1999
96. Berntson GG, Cacioppo JT, Quigley KS: Autonomic determinism: the modes of autonomic control, the doctrine of autonomic space, and the laws of autonomic constraint. Psychol Rev 98(4):459-487, 1991
97. Dubin R, Owens C, Gasper W, Ganz P, Johansen K: Associations of endothelial dysfunction with intradialytic hypotension and hypertension. Hemodial Int 15(3):350-358, 2011
98. Machnik A, Neuhofer W, Jantch J, Dahlmann A, Tammela T, Machura K, Park JK, Beck FX, Müller DN, Derer W, Goss J, Ziomber A, Dietsch P, Wagner H, Van Rooijen N, Kurtz A, Hilgers KF, Alitalo K, Eckhart HU, Luft FC, Kerjaschi D, Tietze J: Macrophages regulate salt-dependent volume and blood pressure by a vascular endothelial factor-C-dependent buffering mechanism. Nat Med 15(5):545-552, 2009
99. Stocker SD, Madden CJ, Sved AF: Excess dietary salt intake alters the excitability of central sympathetic networks. Physiol Behav 100(5):519-524, 2010
100. Munger MA, Ateshkadi A, Cheung AK, Flaharty KF, Stoddard GJ, Marshall EH: Cardiopulmonary events during hemodialysis: effects of dialysis membranes and dialysate buffers. Am J Kidney Dis 36(1):130-139, 2000
101. Van Buren PN, Kim C, Toto R, Inrig JK: Intradialytic hypertension and the association with interdialytic ambulatory blood pressure. Clin J Am Soc Nephrol 6(7):1684-1691, 2011
102. Agarwal R, Light R: Interdialytic hypertension is a marker of volume excess. Nephrol Dial Transplant 25(10):3355-3361, 2010
103. Rockel A, Hennemann H, Sternagel-Haase A, Heidland A: Uraemic sympathetic neuropathy after hemodialysis and transplantation. Eur J Clin Invest 9(1):23-27, 1979
104. Heidbreder E, Schafferhans K, Heidland A: Disturbances of peripheral and autonomic nervous system in chronic renal failure: effects of hemodialysis and transplantation. Clin Nephrol 23(5):222-228, 1985
105. Yildiz A, Sever MS, Demirel S, Akkaya V, Türk S, Tüürkmen A, Ekder T, Ank E: Improvement of autonomic uremic dysfunction after renal transplantation: a heart rate variability study. Nephron 80(1):57-60, 1998
106. Agarwal A, Anand IS, Sajhuja V, Chugh KS: Effect of dialysis and renal transplantation on autonomic dysfunction in chronic renal failure. Kidney Int 40(3):489-485, 1991
107. Studinger P, Lenard Z, Mesrich B, Reusz GS, Kollai M: Determinants of baroreflex function in juvenile end-stage renal disease. Kidney Int 69(12):2236-2242, 2006
108. Kirvela M, Salmela K, Toivonen L, Koivusalo AM, Lindgren L: Heart rate variability in diabetic and non-diabetic renal transplant patients. Acta Anaesthesiol Scand 40(7):804-808, 1996
109. Boucek P, Saudek F, Adamec M, Janousek L, Kaznarova R, Havrdova T, Skibova J: Spectral analysis of heart rate variation following simultaneous pancreas and kidney transplantation. Transpl Proc 35(4):1494-1498, 2003
110. Kurata C, Uehara A, Ishikawa A: Improvement of cardiac sympathetic innervation by renal transplantation. J Nucl Med 45(7):1114-1120, 2004
111. Hausberg M, Lang D, Levers A, Suwelack B, Kisters K, Tokmak F, Barenbrock M, Kosch M: Sympathetic nerve activity in renal transplant patients before and after withdrawal of cyclosporine. J Hypertens 24(5):957-964, 2006
112. McDonough AA: Mechanisms of proximal tubule sodium transport regulation that link extracellular fluid volume and blood pressure. Am J Physiol Regul Integr Comp Physiol 298(4):R851-R861, 2010
113. Cohn JN, Levine TB, Olivari MT, Garberg V, Lura D, Francis GS, Simon AB, Rector T: Plasma norepinephrine as a guide to prognosis in patients with congestive heart failure. N Engl J Med 311(13):819-823, 1984
114. Benedict CR, Shelton B, Johnstone DE, Francis G, Greenberg B, Koustam M, Probstfield Jl, Yusuf S, For the SOLVD investigators: Prognostic significance of plasma norepinephrine in patients with asymptomatic left ventricular dysfunction. Circulation 94(4):690-697, 1996
115. Petersson MJ, Rundqvist B, Johansson M, Eisenhofer G, Lambert G, Herliz H, Jensen G, Friberg P: Increased cardiac sympathetic drive in renovascular hypertension. J Hypertens 20(6):1181-1187, 2002
116. Zoccali C, Enia G, Tripepi G, Panuccio V, Mallamaci F: Clinical epidemiology of major nontraditional risk factors in peritoneal dialysis patients. Perit Dial Int 25(Suppl 3):584-587, 2005
117. Mallamaci F, Tripepi G, Maas R, Malatino L, Böger R, Zoccali C: Analysis of the relationship between norepinephrine and asymmetric dimethyl arginine levels among patients with end-stage renal disease. J Am Soc Nephrol 15(2):435-441, 2004
118. Hayano J, Takahashi H, Toriyama T, Mukai S, Okada A, Sakata S, Yamada A, Ohte N, Kawahara H: Prognostic value of heart rate variability during long-term follow up in chronic haemodialysis patients with end-stage renal disease. Nephrol Dial Transplant 14(6):1480-1488, 1999
119. Hathaway DK, Cashion AK, Milstead J, Winsett RP, Cowan PA, Wicks MN, Gaber O: Autonomic dysregulation in patients awaiting kidney transplantation. Am J Kidney Dis 32(2):221-229, 1998
120. Fukuta H, Hayano J, Ishihara S, Sakata S, Mukai S, Ohte N, Ojika K, Yagi K, Matsumoto H, Sohmiya S, Kimura G: Prognostic value of heart rate variability in patients with end-stage renal disease on chronic hemodialysis. Nephrol Dial Transplant 18(2):318-325, 2003
121. Oikawa K, Ishihara R, Maeda T, Yamaguchi K, Koike A, Kawaguchi H, Tabata Y, Murotani N, Itoh H: Prognostic value of heart rate variability in patients with renal failure on hemodialysis. Int J Cardiol 131(3):370-377, 2009
122. Chandra P, Sands RL, Gillespie BW, Levin NW, Kotanko P, Kiser M, Finkelstein F, Hinderliter A, Pop-Busui R, Rajagopalan S, Saran R: Predictors of heart rate variability and its prognostic significance in chronic kidney disease. Nephrol Dial Transplant 27(2):700-709, 2012
123. Chan CT, Levin NW, Chertow GM, Larive B, Schulman G, Kotanko P: Frequent hemodialysis network daily trial group: determinants of cardiac autonomic dysfunction in ESRD. Clin J Am Soc Nephrol. 5(10):1821-1827, 2010
124. Fukuta H, Hayano J, Ishihara S, Sakata S, Ohte N, Takahashi H, Yokoya M, Toriyama T, Kawahara H, Yajima K, Kobayashi K, Kimura G: Prognostic value of nonlinear heart rate dynamics in hemodialysis patients with coronary artery disease. Kidney Int 64(20):641-648, 2003
125. Nishimura M, Tokoro T, Nishida M, Hashimoto T, Kobayashi H, Yamazaki S, Imai R, Okino K, Iwamoto N, Takahashi H, Ono T: Sympathetic overactivity and sudden cardiac death among hemodialysis patients with left ventricular hypertrophy. Int J Cardiol 142(1):80-86, 2010
126. Johansson M, Gao SA, Friberg P, Annerstedt M, Carlström J, Ivarsson T, Jensen G, Ljungman S, Mathillias O, Nielsen FD, Strömbom U: Baroreflex effectiveness index and baroreflex sensitivity predict all-cause mortality and sudden death in hypertensive patients with chronic renal failure. J Hypertens 25(1):163-168, 2007
127. Tulppo MP, Mäkikallio TH, Seppänen T, Shoemaker K, Tutungi E, Hughson RL, Huikuri HV: Effect of pharmacological adrenergic and vagal modulation on fractal heart dynamics. Clin Physiol 12(5):515-523, 2001
128. Ridha M, Mäkikallio TH, Lopera G, Pastor J, De Marchena E, Chakko S, Huikuri HV, Castellanos A, Myerburg RJ: Effects of carvedilol on heart rate dynamics in patients with congestive heart failure. Ann Noninvasive Electrocardiol 7(2):133-138, 2001
129. Penne EL, Neumann J, Klein IH, Obey PL, Bots ML, Blankestijn PJ: Sympathetic overactivity and clinical outcome in chronic kidney disease patients during standard treatment. J Nephrol 22(2):208-215, 2009
130. Kingwell BA, Thompson JM, Kaye DM, McPherson GA, Jennings GJ, Esler MD: Heart rate spectral analysis, cardiac norepinephrine spillover and muscle sympathetic nerve activity during human sympathetic nervous activation and failure. Circulation 90(1):234-240, 1994
131. Furlan R, Piazza S, Bevilacqua M, Turiel M, Norbiato G, Lombardi F, Malliani A: Pure autonomic failure: complex abnormalities in the neural mechanisms regulating the cardiovascular system. J Auton Nerv System 51(3):223-235, 1995
132. McQuillan RF, Chan CT: The intuitive case for β-blockers in patients with ERSD. Semin Dialysis 25(1):15-21, 2012
133. Cice G, Ferrara L, D'Andrea A, D'Isa S, Di Benedetto A, Cittadini A, Russo PE, Golino P, Calabrò R: Carvedilol increases two-year survival in dialysis patients with dilated cardiomyopathy: a prospective, placebo-controlled trial. J Am Coll Cardiol 41(9):1438-1444, 2003
134. Siddiqi L, Joles JA, Grassi G, Blankestijn PJ: Is kidney ischemia the central mechanism in parallel activation of the renin and sympathetic system? J Hypertens 27(7):1341-1349, 2007
135. Bajaj RR, Wald R, Hackam DG, Gomes T, Perl J, Juurlink DN, Manno M, Garg AX, Kitchlu A, Mamdani MM, Yan AT: Use of angiotensin-converting enzyme inhibitors or angiotensin receptor blockers and cardiovascular outcomes in chronic dialysis patients: a population-based cohort study. Arch Intern Med 172(7):591-593, 2012
136. Hausberg M, Tomak F, Pavenstädt H, Krämer BK, Rump LC: Effects of moxonodine on sympathetic nerve activity in patients with end-stage renal disease. J Hypertens 28(9):1920-1927, 2010
137. Deo SH, Fisher JP, Vianna LC, Kim A, Chockalingham A, Zimmerman MC, Zucker IH, Fadel PJ: Statin therapy lowers muscle sympathetic nerve activity and oxidative stress in patients with heart failure. Am J Physiol Heart Circ Physiol 303(3):H377-H385, 2012
138. Siddiqi L, Joles JA, Oey PL, Blankestijn PJ: Atorvastatin reduces sympathetic activity in patients with chronic kidney disease. J Hypertens 29(1):2176-2180, 2011
139. Lohmeier TE, Iliescu R: Chronic lowering of blood pressure by carotid baroreflex activation. Mechanisms and potential for hypertension therapy. Hypertension 57(5):880-886, 2011
140. Krum H, Schlaich M, Whitbourn R, Sobotka PA, Sadowski J, Bartus K, Kapelak B, Walton A, Sievert H, Thamba S, Abraham WT, Esler M: Catheter-based renal sympathetic denervation for resistant hypertension: a multicentre safety and proof-of-principle cohort study. Lancet 373(9671):1275-1281, 2009
141. Symplicity HTN-1 Investigators: Catheter-based renal sympathetic denervation for resistant hypertension: durability of blood pressure reduction out of 24 months. Hypertension 57(5): 911-917, 2011
142. Hering D, Mahfoud F, Walton AS, Krum H, Lambert GW, Lambert EA, Sobotka PA, Böhm M, Cremers B, Esler MD, Schlaich MP: Renal denervation in moderate to severe CKD. J Am Soc Nephrol 23(7):1250-1257, 2012
143. Di Daniele N, De Francesco M, Violo L, Spinelli A, Simonetti G: Renal sympathetic nerve ablation for the treatment of difficult-to-control or refractory hypertension in a hemodialysis patient. Nephrol Dial Transplant 27(4):1689-1690, 2012
144. Chan CT, Hanly P, Gabor J, Picton P, Pierratos A, Floras JS: Impact of nocturnal hemodialysis on the variability of heart rate and duration of hypoxemia during sleep. Kidney Int 65(2):661-665, 2004
145. Hanly PJ, Pierratos A: Improvement of sleep apnea in patients with chronic renal failure who undergo nocturnal hemodialysis. N Eng J Med 344(2):102-107, 2001
146. Zilch O, Vos PF, Oey PL, Cramer MJ, Ligtenberg G, Koomans HA, Blankestijn PJ: Sympathetic hyperactivity in hemodialysis patients is reduced by short daily hemodialysis. J Hypertens 25(6):1285-1289, 2007